Enrico Smeraldi, MD

Original Research

Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder: A Randomized, Double-Blind Comparison With Sertraline

February 15, 2010

Siegfried Kasper, Göran Hajak, Katharina Wulff, et al

Original Research

Augmentation Effect of Repetitive Transcranial Magnetic Stimulation Over the Orbitofrontal Cortex in Drug-Resistant Obsessive-Compulsive Disorder Patients: A Controlled Investigation

November 10, 2009

Chiara Ruffini, Marco Locatelli, Adelio Lucca, et al

Original Research

Combined Total Sleep Deprivation and Light Therapy in the Treatment of Drug-Resistant Bipolar Depression: Acute Response and Long-Term Remission Rates.

December 15, 2005

Francesco Benedetti, Barbara Barbini, Mara Cigala Fulgosi, et al

Original Research

Does rTMS Hasten the Response to Escitalopram, Sertraline, or Venlafaxine in Patients With Major Depressive Disorder? A Double-Blind, Randomized, Sham-Controlled Trial

December 15, 2005

David Rossini, Lorenzo Magri, Adelio Lucca, et al

Letter to the Editor

Reply to "Cardiopulmonary Complications of Ergot-Derivative Dopamine Agonists"

October 15, 2004

Roberto Cavallaro, Federica Cocchi, Enrico Lattuada, et al

Original Research

Cabergoline Treatment of Risperidone-Induced Hyperprolactinemia: A Pilot Study

February 1, 2004

Roberto Cavallaro, Federica Cocchi, Sara M Angelone, et al

Original Research

Morning Light Treatment Hastens the Antidepressant Effect of Citalopram: A Placebo-Controlled Trial

June 15, 2003

Francesco Benedetti, Cristina Colombo, Adriana Pontiggia, et al

Original Research

Venlafaxine Versus Fluvoxamine in the Treatment of Delusional Depression: A Pilot Double-Blind Controlled Study

June 30, 2000

Raffaella Zanardi, Linda Franchini, Alessandro Serretti, et al

Original Research

Two-Year Maintenance Treatment With Citalopram, 20 mg, in Unipolar Subjects With High Recurrence Rate

December 31, 1999

Linda Franchini, Raffaella Zanardi, Mariangela Gasperini, et al

Original Research

Dose-Response Efficacy of Paroxetine in Preventing Depressive Recurrences: A Randomized, Double-Blind Study

May 15, 1998

Linda Franchini, Mariangela Gasperini, Jorge Perez, et al

Original Research

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder

March 15, 1998

Francesco Benedetti, Laura Sforzini, Cristina Colombo, et al

Original Research

A Double-Blind Study of Long-Term Treatment With Sertraline or Fluvoxamine for Prevention of Highly Recurrent Unipolar Depression

March 15, 1997

Linda Franchini, Mariangela Gasperini, Jorge Perez, et al

Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder: A Randomized, Double-Blind Comparison With Sertraline

Augmentation Effect of Repetitive Transcranial Magnetic Stimulation Over the Orbitofrontal Cortex in Drug-Resistant Obsessive-Compulsive Disorder Patients: A Controlled Investigation

Combined Total Sleep Deprivation and Light Therapy in the Treatment of Drug-Resistant Bipolar Depression: Acute Response and Long-Term Remission Rates.

Does rTMS Hasten the Response to Escitalopram, Sertraline, or Venlafaxine in Patients With Major Depressive Disorder? A Double-Blind, Randomized, Sham-Controlled Trial

Reply to "Cardiopulmonary Complications of Ergot-Derivative Dopamine Agonists"

Cabergoline Treatment of Risperidone-Induced Hyperprolactinemia: A Pilot Study

Morning Light Treatment Hastens the Antidepressant Effect of Citalopram: A Placebo-Controlled Trial

Venlafaxine Versus Fluvoxamine in the Treatment of Delusional Depression: A Pilot Double-Blind Controlled Study

Two-Year Maintenance Treatment With Citalopram, 20 mg, in Unipolar Subjects With High Recurrence Rate

Dose-Response Efficacy of Paroxetine in Preventing Depressive Recurrences: A Randomized, Double-Blind Study

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder

A Double-Blind Study of Long-Term Treatment With Sertraline or Fluvoxamine for Prevention of Highly Recurrent Unipolar Depression

ELSEWHERE:

FOLLOW US:

Enrico Smeraldi, MD

Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder: A Randomized, Double-Blind Comparison With Sertraline

Augmentation Effect of Repetitive Transcranial Magnetic Stimulation Over the Orbitofrontal Cortex in Drug-Resistant Obsessive-Compulsive Disorder Patients: A Controlled Investigation

Combined Total Sleep Deprivation and Light Therapy in the Treatment of Drug-Resistant Bipolar Depression: Acute Response and Long-Term Remission Rates.

Does rTMS Hasten the Response to Escitalopram, Sertraline, or Venlafaxine in Patients With Major Depressive Disorder? A Double-Blind, Randomized, Sham-Controlled Trial

Reply to "Cardiopulmonary Complications of Ergot-Derivative Dopamine Agonists"

Cabergoline Treatment of Risperidone-Induced Hyperprolactinemia: A Pilot Study

Morning Light Treatment Hastens the Antidepressant Effect of Citalopram: A Placebo-Controlled Trial

Venlafaxine Versus Fluvoxamine in the Treatment of Delusional Depression: A Pilot Double-Blind Controlled Study

Two-Year Maintenance Treatment With Citalopram, 20 mg, in Unipolar Subjects With High Recurrence Rate

Dose-Response Efficacy of Paroxetine in Preventing Depressive Recurrences: A Randomized, Double-Blind Study

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder

A Double-Blind Study of Long-Term Treatment With Sertraline or Fluvoxamine for Prevention of Highly Recurrent Unipolar Depression

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles